(Q41024331)

25 September 2017

Orally administered N-acetylcysteine may improve general well-being in patients with mild chronic bronchitis (English)

1 reference

25 September 2017

1 reference

Hansen NC

1

1 reference

25 September 2017

Skriver A

2

1 reference

25 September 2017

Brorsen-Riis L

3

1 reference

25 September 2017

Balsløv S

4

1 reference

25 September 2017

Evald T

5

1 reference

25 September 2017

Maltbaek N

6

1 reference

25 September 2017

Gunnersen G

7

1 reference

25 September 2017

Garsdal P

8

1 reference

25 September 2017

Sander P

9

1 reference

25 September 2017

Pedersen JZ

10

1 reference

25 September 2017

1 August 1994

1 reference

25 September 2017

1 reference

25 September 2017

88

1 reference

25 September 2017

531-535

1 reference

25 September 2017

7

1 reference

A controlled trial of intermittent oral acetylcysteine in the long-term treatment of chronic bronchitis

25 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980337-3

7 January 2021

inferred from DOI database lookup

Oral N-acetylcysteine and exacerbation rates in patients with chronic bronchitis and severe airways obstruction. British Thoracic Society Research Committee

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980337-3

7 January 2021

inferred from DOI database lookup

Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0954-6111%2805%2980337-3

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0954-6111(05)80337-3

1 reference

release_c4vpk5wmwbc75egm3j2nzifomi

25 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c4vpk5wmwbc75egm3j2nzifomi

24 November 2022

mapped directly with Wikidata item

1 reference